chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Strong metallic taste; Fever; This is a spontaneous report from a non-contactable consumer, the patient. A 20-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 02May2021 at 17:00 (at the age of 20-year-old) as a single dose for COVID-19 immunisation. Medical history included allergy to salmon. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included unspecified anti-depressants and  Attention Deficit Hyperactive Disorder (ADHD) medications from unknown dates for unknown indications. The patient previously received lamotrigine (LAMICTAL) for unknown indication on an unknown date and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 11Apr2021 (at the age of 20-year-old) as a single dose for COVID-19 immunisation. On 03May2021, the patient experienced fever. On 04May2021, the patient had strong metallic taste (also reported as since as of today 11 days) which did not go away with tooth brushing or gum. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events fever and strong metallic taste was unknown at the time of the report.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
This spontaneous report as received from a physician via a company representative, refers to a patient of unknown age and gender. The patient's conditions and medical history were not reported. On 22-SEP-2015, the patient was vaccinated with an improperly stored dose of GARDASIL 9 "0.5ml Pk SD PFS-Leur-Lok" which had lot number of L001312 and expiration date on 24-FEB-2017 (route of administration and anatomical location were not reported). There were no concomitant medications provided. No adverse effects reported. No product quality complaint was involved. On an unspecified dates, the GARDASIL 9 vaccine had two temperature excursions; one of 24 hours and other one of 32 hours. The lowest recorded temperature was 34 F (1.111111111 Celsius) and the highest recorded temperature was 48 F (8.888888889 Celsius). The vaccine status was reported as "in excursion". The vaccine storage criteria and the vaccine excursion were reported and "Refrigerator(R)". This is one of several cases from the same reporter. Additional information has been requested.
Chest tightness, chest squeezing, right-sided chest pain.  ER visit testing all negative.  FU cardiologist diagnosed vaccine-related myocarditis.
Slight shortness of breath. Some heart heart palpitations. Chills. Fever of 100.5.
neck and face are itchy; rash; This case was reported by a consumer via interactive digital media and described the occurrence of pruritus facial in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On 26th April 2022, the patient received Shingles vaccine. On 30th April 2022, 4 days after receiving Shingles vaccine, the patient experienced pruritus facial and rash. On an unknown date, the outcome of the pruritus facial and rash were not recovered/not resolved.   It was unknown if the reporter considered the pruritus facial and rash to be related to Shingles vaccine.     Additional Information: GSK Receipt Date: 30-April-2022 Reporter's comment: The patient had a shingles shot last Tuesday and on the reporting day patient's neck and face were itchy and had a rash asked did patient need to be concerned. Additional supportive information: Follow-up would not possible as no contact details were available.
Information has been received from a Nurse Practitioner (N.P.) concerning a 64 year old female with sulfa, penicillin and food allergies who on 26-MAY-2009 was vaccinated intramuscularly with a 0.5 ml dose of PNEUMOVAX (lot # 663012/1163X). There was no concomitant medication. On 28-May-2009 the patient developed cellulitis near the injections site after receiving the vaccine. It was reported that the patient had the 3 by 6 inches swollen red area which extended from deltoid to the elbow. The area was very painful and itchy. The patient sought medical attention and came to the physician's office. As of 28-MAY-2009 the patient did not recovered. Additional information has been requested.
Swollen eyes, difficulty breathing. Given 0.2mg epinephrine, 25mg BENADRYL and 50mg SOLUMEDROL with resolution of swollen eyes and improved breathing.
The patient presents with skin irritation.  The symptoms began 3 days ago.   Two weeks ago pt had his shots.  3 days ago in the same area pt had shots he develpoed rash like bumps then the area doubled in size over night and became red, hot, and hard. Reviewed above no fever, hx of egg allergy.  Scratching when pants off, immunizations. 11 days ago immunized 11 days ago in area of rxn. No other exposures
UrticariaPruritus Tingling of upper lip and under eyes Narrative: 12:45 stated upper lip felt fingly and under eyes; VS 73, r 16, BP 1589/90, sat 98%. ambulated to MD office Evaluated by Dr. Benadryl ordered (25mg PO x 1 dose) and given at 1305). Ambulated back to personal office, called friend to pick up after work. 1330, 72, 16, 96%, 135/82, denies worsening of symptoms, no rash or hives noted. No symptoms of difficulty breathing, swelling of face or tongue, increased heart rate, rash or dizziness or head ache. Assessment and follow up by M.D.
12/15/2021 around 12:15 p.m. I had an extremely fast heartbeat that was so quick and rapid that I had to sit down and was struggling to catch my breath and was feeling dizzy. Sometime between 5 and 15 minutes, this intense heartbeat subsided and my heartbeat finally returned to normal.
Systemic inflammatory reaction; Headache; Rigors (described as uncontrolled extreme chills); Nausea; Fever; Fast heartbeat; Trouble breathing; Sore arms; Swelling; Redness at injection site; sick; This case was reported by a consumer via call center representative and described the occurrence of inflammatory reaction in a 69-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix with an associated reaction of pyrexia (1st dose received on an unknown date, reference case US2021AMR008025).   On 9th January 2021, the patient received the 2nd dose of Shingrix (intramuscular). On 9th January 2021, less than a day after receiving Shingrix, the patient experienced inflammatory reaction, headache, rigors, nausea, fever, heartbeats increased, difficulty breathing, pain in arm, swelling, injection site erythema and sickness. Rechallenge with Shingrix was positive. On an unknown date, the outcome of the inflammatory reaction, rigors, fever, heartbeats increased, difficulty breathing, pain in arm, swelling and sickness were recovered/resolved and the outcome of the headache, nausea and injection site erythema were not recovered/not resolved.   It was unknown if the reporter considered the inflammatory reaction, headache, rigors, nausea, fever, heartbeats increased, difficulty breathing, pain in arm, swelling, injection site erythema and sickness to be related to Shingrix.  Additional details were provided as follows: The patient had reported the case for herself. The patient received the 2nd dose of Shingrix past Saturday at Pharmacy in her upper left arm. The patient became so sick that evening and she experienced a headache, rigors (described as uncontrolled extreme chills), nausea, fever, fast heartbeat and trouble breathing (when getting up to use the bathroom), sore arms, swelling and redness at the injection site.  The symptoms had resolve except she still had a little headache, nausea and redness at the injection site. The patient had same reaction when she got the 1st dose, but without the breathing problems and rigors and was only half as bad as the reaction from the 2nd dose. The patient was in shape and works out. The patient gave permission to follow-up with her health care professional. The patient did not have health care professional's email/fax at the time of reporting.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR008025:Same reporter
Having some discomfort in her chest; Heart is beating fast; This is a spontaneous report from a contactable consumer (parent). A 19-year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), dose 2 via an unspecified route of administration on 04May2021 as DOSE 2, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), dose 1 via an unspecified route of administration on an unspecified date as DOSE 1, SINGLE for covid-19 immunisation. The patient experienced having some discomfort in her chest, heart is beating fast on an unspecified date. Reporter stated, her 19-year-old daughter had her second Pfizer vaccination today and she was having some discomfort in her chest and her heart was beating fast and we just want to make sure you know if that was normal or that was something to be concerned about. The patient underwent lab tests and procedures which included heart rate: fast on May2021. The clinical outcome of the events was unknown.   No follow up attempts are possible; information about lot/batch number cannot be obtained.
Moderna Vaccine administered IM as above. Patient stood up to walk to observation site in clinic, approximately 20 feet from vaccination site. Looked pale, diaphoretic. I observed the patient at 1032 with her listing to her right side. She was unresponsive to verbal stimuli. Patient placed on floor with legs elevated. SaO2 98/HR 55.  EMS at site at 1033. EKG leads attached showed NSR. APN on site evaluated patient, who quickly recovered her LOC, and began speaking to paramedics. Alert/Oriented x 3. Followed all commands. Patient admitted to not eating much that morning (small breakfast bar) and not much else to drink. She was waiting outdoors in warm environment for approximately 2 hours prior to receiving her vaccination.
This spontaneous report as received from a healthcare worker refers to an approximately 1 year old patient of unknown gender. On 15-OCT-2013 at 09:15 the patient was administered with M-M-R II (lot number H018184, expiry date 05-OCT-2014) (dosing regimen and frequency unknown) that was exposed to a cumulative time of 9.5 hours at temperatures of 8.0 degrees centigrade to 13.9 degrees centigrade. The patient experienced no adverse event. On the following date M-M-R II was exposed approximately for 9.5 hours at temperatures of 8.0 degrees centigrade to 13.9 degrees centigrade, on 07-OCT-2013 from 17:14 to 18:08 the vaccine experienced a temperature of 9.4 degrees centigrade, on 10-OCT-2013 from 09.50 to 13.26 the vaccine experienced a temperature of 13.9 degrees centigrade, on 14-OCT-2013 from 13:56 to 16:08 the vaccine experienced a temperature of 12.8 degrees centigrade, on 17-OCT-2013 from 08:38 to 09:44 the vaccine experienced a temperature of 9.7 degrees centigrade, on 18-OCT-2013 from 11:50 to 13:08 the vaccine experienced a temperature of 9.7 degrees centigrade. This is one of the 17 reports received from same reporter. Additional information has been requested.
blood pressure elevation; heart rate is really high up to 100 at rest; rash on hands; injection site rashes; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 26-Feb-2021 and was forwarded to Moderna on 27-Feb-2021.    This spontaneous case was reported by a consumer and describes the occurrence of BLOOD PRESSURE MEASUREMENT (blood pressure elevation), HEART RATE INCREASED (heart rate is really high up to 100 at rest), RASH (rash on hands) and INJECTION SITE RASH (injection site rashes) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 24-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Feb-2021, the patient experienced BLOOD PRESSURE MEASUREMENT (blood pressure elevation), HEART RATE INCREASED (heart rate is really high up to 100 at rest), RASH (rash on hands) and INJECTION SITE RASH (injection site rashes). At the time of the report, BLOOD PRESSURE MEASUREMENT (blood pressure elevation), HEART RATE INCREASED (heart rate is really high up to 100 at rest), RASH (rash on hands) and INJECTION SITE RASH (injection site rashes) outcome was unknown.
Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Fatigue) in a 36-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002C21A and 036C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 22-Apr-2021, the patient experienced FATIGUE (Fatigue). At the time of the report, FATIGUE (Fatigue) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   This case was linked to MOD-2021-423971 (Patient Link).   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 23-Dec-2021: Non significant follow up
Left facility after 15 minutes. Approximately 4-5 minutes later experienced sudden flushed very warm face and red skin), dizziness, chills/tremors, and drop in blood pressure (feeling faint). Went back to observation site to ensure monitoring. No breathing issues occurred. Remained there for 25 minutes until heart rate stabilized.  Went home and took Benadryl. Skin reaction persisted for approx 2 hours post vaccination. I have a history of severe allergies (gastrointestinal and skin symptoms) and eczema.
vomiting; This is a spontaneous report from a contactable consumer (reporting for his wife). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, batch/lot number and expiration date were unknown), via an unspecified route of administration on 18Jan2021 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced vomiting on 18Jan2021. The reporter mentioned that he and his wife (patient) received the vaccine yesterday (18Jan2021). His wife has experienced vomiting since last night, earlier this morning, and 20 minutes before the call. He was asking if this was a normal side effect and for any recommendations on what they should do. His wife has been vomiting since getting the COVID-19 vaccine. He said he was trying to see if vomiting is one of the side effects of the COVID-19 vaccine. The outcome of the event was unknown.   Information about batch/lot number has been requested.
Got the vaccine at 9:15 am on Monday. Around 3 pm I started feeling pain in my arm, running down into my fingers, and had trouble lifting my arm. I began to feel muscle aches in my body. By 7 pm I had severe shakes and shivers with teeth chattering uncontrollably. Severe chills. I could not lift my arm above shoulder level and felt like I'd been punched hard in the shoulder. It was hard to move my body from a seated position or move when I was lying down because of the pain in my arm. Around 10 pm I began to have nausea but did not vomit. At 4 am I awoke and had mild diarrhea. I thought I might pass out. Throughout the night I was sweating excessively, although I did not have a fever. By 8:30 am on Tuesday the shakes and chills had reduced to a moderate level. I had to call in sick to work. I had muscle aches, pain in my arm that continued to radiate to my hand, and continued to sweat. I felt fatigue and slept most of the day. I had a headache. I continued to have some nausea and diarrhea. My appetite was very reduced.  I went to sleep with the chills at 6:30 pm. I continued to sweat through my night clothes. When I awoke around 6:30 am on Wednesday morning, I had a headache and was very shaky (I have an essential tremor that is normally mild and it was very bad in the morning). I had very low energy. I ate breakfast and noted that my appetite had not completely returned, but I didn't feel nausea. The headache continued until I took 2 Advil around 11 am. I felt progressively better over the course of the day, returning to almost normal by around 5 pm.
DAD STATES CHILD HAD IMMUNIZATIONS ON 4/13/17 AND WOKE 4/14/2017 WITH BRUISES ALL OVER, HE HAD RECEIVED THE MMR 1 MO PRIOR. NO OTHER SYMPTOMS.
lightheaded; headache; nausea; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (lightheaded), HEADACHE (headache) and NAUSEA (nausea) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     no medical history was provided by reporter.     On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (lightheaded), HEADACHE (headache) and NAUSEA (nausea). At the time of the report, DIZZINESS (lightheaded), HEADACHE (headache) and NAUSEA (nausea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication included antidepressant, blood pressure medication, heart pill Treatment medication was taking medication for the headache, but nothing for the nausea
On 11/9/00, during doctor visit, pt received injection of the pneumovax 23 in left arm, deltoid region. Pt returned on 11/10/00 with redness, heat and swelling in band-like region around left arm injection site. Treated with Keflex.
Fever 102-104F, severe pain in the entire body, head, knees, spine, especially abdominal area. The condition like that lasted for 2 days and the patient didn't eat and stayed in bed. The patient decided not to call for any medical help due to the lack of trust that more damage will not be caused to her.
On 9/26/10, the patient developed midsternal chest pain. Evaluation within a short time showed a "black shadow" on chest xray which was diagnosed as pneumonia and treated with Azithromycin. She then started with vomiting which has continued about 1-2 times per week. She left school feeling weak and pale at the beginning of the vomiting episodes. Fever has been intermittent about once a week. This is not documented rather tactile fever. Her weight has also waxed and waned up and down. She has only once experienced any dyspnea at PE class. She had one bout of hematemesis. She was seen in the ED (July 2010) and was evaluated for pulmonary embolus and the results excluded the embolus but revealed multiple pulmonary nodules. The biopsy (performed in August 2010) showed a vasculitis of the small and medium vessels and a bronchiolitis obliterans. She started taking prednisone and methotrexate in August 2010. She is currently being followed in Pediatric Rheumatology at hospital.
A report has been received from a physician concerning a male premature baby. Medical history and information about concomitant drugs was not provided. On 16-Dec-2015, during the 29th week of the pregnancy the mother received FLUMIST QUADRIVALENT (intranasal) for the safety of the pregnancy. During the 35th week of gestation the baby was born with 5.93 pounds. Delivery was expected on 01-Mar-2016. The mother did not used any hormonal contraception at the time of conception. Heart murmurs and mild pulmonary stenosis were observed after the delivery. The outcome of the events was unknown. The report was considered to be non-serious by the company physician.
On 3/29/21, 1 week after vaccine administration patient noticed  a rash near the injection site. On 3/31/21 she had hives down the same arm. Patient is taking Benadryl to help treat the rash.
I have armpit swelling to the point where is was incredibly painful, I had to go to an urgent care center and they performed a procedure there to have it drained.
No adverse Event; Patient got vaccinated after BUD; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD) and NO ADVERSE EVENT (No adverse Event) in a 56-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 084J21A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 19-Apr-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 19-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse Event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD) and NO ADVERSE EVENT (No adverse Event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse Event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient got vaccinated after BUD).    No concomitant medication was reported.    It was reported that, the patient received vaccine after the beyond use-by date. No treatment information was reported. Patient registration ID reported.
Information has been received from a physician concerning a female who in October 2007, was vaccinated with ZOSTER vaccine injection, and "over this past weekend", on approximately 30-AUG-2008, the patient developed shingles. The patient was recovering from shingles. As of 3-SEP-2008, the date of this report, the patient sought unspecified medical attention. Additional information has been requested.
On 9-15-11 pt was given a flu shot, and next day broke out with hives all over stomach, arms, legs. Dr. looked over and Rx'd prednisone, OTC BENADRYL.
vaccinated pt intradermally. however, half of jynneos vaccine content leaked out of patient. Pt was revaccinated.
This is a spontaneous report from a contactable consumer. This 36-year-old non-pregnant female patient received bnt162b2 (COVID-19-VACCINE, Solution for injection, Lot number: EL9267), via an unknown route of administration on Left arm on 10Feb2021 13:45 (at the age of 36-year-old) at dose 1, single for COVID-19 immunisation. Medical history included Sjogrins. Concomitant medications were not reported. The patient did not receive any other vaccine in four weeks. The patient did not receive any other medications in two weeks. The patient had no covid prior vaccination. The patient was not covid tested post vaccination. The patient had no known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. On 10Feb2021 at 14:00, the patient experienced sore arm. The patient did not receive any treatment for the reported event. Outcome of the event was recovered in 2021. Follow-up attempts completed. No further information expected.
Large cold sore (herpes blisters) left side-lower lip 6 days after vaccine-never had this before only once on upper lip right side 20 yrs. ago. I was very healthy when I received this vaccine.